New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation:: A retrospective study

被引：2
|
作者：
Côté, L
Deschêsnes, L
de Cotret, PR
Lachance, JG
Noël, R
Isenring, P
Houde, I
机构：
[1] CHUQ, Quebec Hosp, Hotel Dieu, Nephrol Serv, Quebec City, PQ, Canada
[2] CHUQ, Quebec Hosp, Hotel Dieu, Infect Dis Serv, Quebec City, PQ, Canada
[3] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期
关键词：
D O I：
10.1016/S0041-1345(01)02560-X
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：3626 / 3629
页数：4
相关论文
共 50 条
  • [31] Evaluation of immunosuppressive regimens on the incidence of new-onset diabetes mellitus after kidney transplantation: 24-Month analysis of the ELEVATE study
    Chadban, Steve
    de Fijter, Johan W.
    Holdaas, Hallvard
    Rostaing, Lionel
    Urrea, Eduardo Mancilla
    Bernhardt, Peter
    Lopez, Patricia
    Dong, Gaohong
    Cruzado, Josep
    van der Giet, Markus
    TRANSPLANTATION, 2016, 100 (07) : S396 - S396
  • [32] Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study
    Bellini, Arianna
    Finocchietti, Marco
    Rosa, Alessandro Cesare
    Nordio, Maurizio
    Ferroni, Eliana
    Massari, Marco
    Alegiani, Stefania Spila
    Masiero, Lucia
    Bedeschi, Gaia
    Cardillo, Massimo
    Lucenteforte, Ersilia
    Piccolo, Giuseppe
    Leoni, Olivia
    Pierobon, Silvia
    Ledda, Stefano
    Garau, Donatella
    Davoli, Marina
    Addis, Antonio
    Belleudi, Valeria
    PLOS ONE, 2024, 19 (01):
  • [33] Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study
    Sarmiento, JM
    Munn, SR
    Paya, CV
    Velosa, JA
    Nguyen, JH
    CLINICAL TRANSPLANTATION, 1998, 12 (05) : 371 - 374
  • [34] NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation
    Leone, Francesca
    Gigliotti, Paolo
    La Russa, Antonella
    Lofaro, Danilo
    Perri, Anna
    Vizza, Donatella
    Lupinacci, Simona
    Toteda, Giuseppina
    Bonofiglio, Martina
    Presta, Pierangela
    Talarico, Roberta
    Aquino, Benedetta
    Bonofiglio, Renzo
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (01)
  • [35] Cytomegalovirus infection and kidney transplantation- A retrospective study of risk factors and long-term clinical outcome
    Rajendiran, Aravinth Kumar
    Jeyachandran, Dhanapriya
    Gopalakrishnan, Natarajan
    Arumugam, Venkatesh
    Thanigachalam, Dineshkumar
    Ramanathan, Sakthirajan
    INDIAN JOURNAL OF TRANSPLANTATION, 2021, 15 (02) : 125 - 130
  • [36] New immunosuppressive treatment in kidney transplantation
    Di Landro, D
    Sarzo, G
    Marchini, F
    CLINICAL NEPHROLOGY, 2000, 53 (04) : B23 - B32
  • [37] THE USE OF SIROLIMUS IN PATIENTS WITH RECURRENT CYTOMEGALOVIRUS (CMV) INFECTION AFTER KIDNEY TRANSPLANTATION. A RETROSPECTIVE CASE SERIES ANALYSIS
    Hung, Rachel
    Shendi, Ali
    Caplin, Ben
    Griffiths, Paul
    Harber, Mark
    TRANSPLANT INTERNATIONAL, 2017, 30 : 253 - 254
  • [38] Detrimental impact of immunosuppressive burden on clinical course in patients with Cytomegalovirus infection after liver transplantation
    Ossami Saidy, Ramin Raul
    Kollar, Stefanie
    Czigany, Zoltan
    Dittrich, Luca
    Raschzok, Nathanael
    Globke, Brigitta
    Schoening, Wenzel
    Oellinger, Robert
    Lurje, Georg
    Pratschke, Johann
    Eurich, Dennis
    Uluk, Deniz
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [39] Cytomegalovirus infection in kidney transplantation: Prophylaxis and management
    Bulinski, P
    ToledoPereyra, LH
    Dalal, S
    Hernandez, G
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3310 - 3311
  • [40] Cytomegalovirus Infection following Kidney Transplantation: a Multicenter Study of 3065 Cases
    Einollahi, B.
    INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2012, 3 (02): : 74 - 78
12345